Tech Xplore on MSN
AI-driven assistant calculates best injection molding settings and explains decisions in multiple languages
Most of the plastic products we use are made through injection molding, a process in which molten plastic is injected into a ...
A new clinical trial demonstrates that hepatocyte growth factor plasmid therapy with AMG0001 is a promising, nonsurgical ...
DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID ...
NEW HAVEN, Conn., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for VYD2311, an ...
Zoliflodacin, which will be marketed under the name Nuzolvence, is the first new drug to uniquely target gonorrhea infections in decades, and the first developed as part of a public-private ...
Indivior PLC today announced results from a randomized, double-blind clinical trial published in JAMA Network Open. The study found that both the 100-mg and 300-mg monthly maintenance doses ...
Most of the plastic products we use are made through injection molding, a process in which molten plastic is injected into a mold to mass-produce ...
Most of the plastic products we use are made through injection molding, a process in which molten plastic is injected into a mold to mass-produce ...
US FDA approves Innoviva’s Nuzolvence, a first-in-class, single-dose, oral antibiotic to treat uncomplicated urogenital gonorrhoea in adults?and adolescents: Waltham, Massachuse ...
Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. , today announced that the U.S. Food and Drug Administration (FDA) has approved NUZOLVENCE® (zoliflodacin) for oral suspension, a ...
Health and Me on MSN
36% Of Rabies Death Comes From India: This Is What You Should Do After A Dog Bite, Explains Doctor
India accounts for over one-third of global rabies deaths, warns WHO. Doctors say rabies can spread through bites or ...
FDA approves FUROSCIX- for use in pediatric patients weighing 43kg or aboveUSPTO issues five patents for FUROSCIX ReadyFlow Autoinjector WESTLAKE VILLAGE, Calif. and BURLINGTON, Mass., Dec. 23, 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results